Docosahexaenoic Acid (DHA) Reduces LPS-Induced Inflammatory Response Via ATF3 Transcription Factor and Stimulates

Katarzyna Wieczorek-Szukala1, Monika Markiewicz2, Anna Walczewska1

  • 1Department of Cell-to-Cell Communication, Medical University of Lodz, Lodz, Poland.

Abstract

Insights

Docosahexaenoic acid (DHA) reduces neuroinflammation by inhibiting pro-inflammatory mediators and enhancing microglial phagocytic activity. This suggests DHA may protect the brain from damage in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Microglial cells are key in neuroinflammation, but chronic activation drives neurodegeneration.
  • Identifying factors to limit microglial activation is crucial for treating neurodegenerative diseases.

Purpose of the Study:

  • To investigate the effects of docosahexaenoic acid (DHA) on microglial inflammatory response.
  • To examine DHA's impact on TREM2-dependent phagocytic activity in microglia.

Main Methods:

  • Primary microglia were treated with DHA and lipopolysaccharide (LPS).
  • Gene and protein expression (ATF3, TREM2, TREM2, Syk, Akt) were analyzed via RT-PCR and Western Blot.
  • Cytokine/chemokine profiles and phagocytic activity were assessed.

Main Results:

  • DHA increased ATF3 expression and enhanced microglial phagocytosis.
  • DHA significantly reduced pro-inflammatory mediators (chemokines, cytokines, ICAM-1).
  • DHA promoted Src/Syk kinase activation.

Conclusions:

  • DHA effectively inhibits the release of pro-inflammatory mediators via ATF3.
  • DHA enhances microglial phagocytic capacity.
  • DHA offers a potential therapeutic mechanism to mitigate neuroinflammation and neuronal damage.